EDITORIAL [Hot topic: RAS-A Central Feature in Cancer Targeted Therapy (Guest Editor: Balazs Gyorffy)

B Gyorffy - Current Cancer Drug Targets, 2010 - ingentaconnect.com
The new millennium brought the transition from classical therapy to targeted cancer therapy.
Although multiple pathways are involved in cancer initiation and progression, the RAS …

[PDF][PDF] Identification of a KEAP1 Germline Mutation in a Family with Multinodular

R Teshiba, T Tajiri, K Sumitomo, K Masumoto… - 2013 - pdfs.semanticscholar.org
Background: The familial clustering of multinodular goitres (MNGs) with a dominant mode of
inheritance has been repeatedly reported. Linkage studies have revealed several genetic …

[HTML][HTML] Novel RAAS agonists and antagonists: clinical applications and controversies

CA Romero, M Orias, MR Weir - Nature Reviews Endocrinology, 2015 - nature.com
The renin–angiotensin–aldosterone system (RAAS) regulates blood pressure homeostasis
and vascular injury and repair responses. The RAAS was originally thought to be an …

[引用][C] Werner & Ingbar's The Thyroid: A Fundamental & Clinical Text 9th Edition

TM Goiter, D Führer, K Krohn, R Paschke

Effect of activator of G-protein signaling 3 (AGS3) on prostate tumorigenesis

TO Adekoya, N Smith, T Mowatt, T Aladeniyi… - Cancer Research, 2018 - AACR
Prostate cancer (PCa) is a leading cause of cancer death among men, with greater
prevalence of the disease among the African American population in the US. Activator of G …

Oncogenic Ras-Induced Interleukin-6 Promotes Tumor Growth

JF Foley - Science's STKE, 2007 - science.org
Ras is a membrane-bound small guanosine triphosphatase (GTPase) that mediates signals
from receptor tyrosine kinases to members of the mitogen-activated protein kinase (MAPK) …

[HTML][HTML] Biomarkers in thyroid tumor research: new diagnostic tools and potential targets of molecular-based therapy

O Gimm, MD Castellone, C Hoang-Vu… - Journal of Thyroid …, 2011 - ncbi.nlm.nih.gov
Thyroid cancer's incidence has increased dramatically over the last years and it now
accounts for 2.6% of all new cancers when epithelial skin cancers are excluded. This …

ERRATUM FOR 10.1210/jc. 2013-2449

SG Ball, RA James, R Quinton, S Chen… - J Clin Endocrinol …, 2015 - academic.oup.com
This article has been published under the terms of the Creative Commons Attribution
License (CC-BY; https://creativecommons. org/licenses/by/4.0/), which permits unrestricted …

Detection of novel genetic changes in the ras genes in papillary thyroid carcinoma

V Sykorova, E Vaclavikova, S Dvorakova… - Endocrine …, 2012 - endocrine-abstracts.org
Methods: DNA was extracted from 72 fresh frozen thyroid samples and 26 paraffin-
embedded formalin-fixed samples. The cohort contained 83 PTCs (56 FVPTCs, 14 mixed …

Activation of mitogen-activated protein kinase is necessary but not sufficient for proliferation of human thyroid epithelial cells induced by mutant Ras

V Gire, CJ Marshall, D Wynford-Thomas - Oncogene, 1999 - nature.com
Given the high frequency of ras oncogene activation in several common human cancers, its
signal pathways are an important target for novel therapy. For practical reasons, however …